Quarterly results, annual reports, SEC filings, news, stock info, stock quote, stock chart, historical stock quote, investment calculator, dividend & split ...

For the full year 2023, we reported revenues of $58.5 billion, reflecting an operational decrease of 41% year over year, primarily due to a significant decline ...

Pfizer Inc. 2021 Annual Report View Annual Report Download. Pfizer Inc. 2020 Annual Report View Annual Report Download. Pfizer Inc. 2019 Annual Report View ...

Pfizer collaborated with the German biotechnology company BioNTech SE to jointly develop a COVID-19 vaccine using BioNTech's messenger RNA (mRNA) ...

16 авг. 2024 г. · With a strong local manufacturing base contributing ~70% of our business operations, including ~ 4 billion tablets being produced annually from ...

Analysis of Financial Condition and Results of Operations in Pfizer's 2022 Annual Report on Form 10-K for additional information. PFIZER INC.

Quarterly Reports, Annual Reports, SEC Filings, Viatris Transaction, Investor News, Stock Information, Historical Stock Chart & Data, Investment Calculator

Revenues decreased $1.9 billion, or 4%, to $51.8 billion in 2019 from $53.6 billion in 2018, reflecting an operational decrease of $545 million, or 1%, and an ...

31 янв. 2023 г. · Full-Year 2022 Reported Diluted EPS(2) of $5.47, Up 42% Year-Over-Year, and Adjusted Diluted EPS(3) of. $6.58, Up 62% Year-Over-Year, ...

Revenues in 2018 increased by $1.1 billion, or 2%, compared to 2017, which reflects operational growth of $791 million, or 2%, and the favorable impact of ...